SCHEMBL9905070

SCHEMBL9905070

CCCCc1cc([N+](=O)[O-])cc(C(=O)O)c1CCCC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.45
TP53 P04637 1/20 0.45
AKR1B1 P15121 1/20 0.43
EIF4A1 P60842 7/20 0.43
GABRP O00591 1/20 0.43
GABRD O14764 1/20 0.43
GABRA1 P14867 1/20 0.43
GABRB1 P18505 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA5 P31644 1/20 0.43
GABRA3 P34903 1/20 0.43
GABRA2 P47869 1/20 0.43
GABRB2 P47870 1/20 0.43
GABRA4 P48169 1/20 0.43
GABRE P78334 1/20 0.43
GABRA6 Q16445 1/20 0.43
GABRG1 Q8N1C3 1/20 0.43
GABRG3 Q99928 1/20 0.43
GABRQ Q9UN88 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9568711 0.86 HTT (0.45) HTTTP53AKR1B1EIF4A1LMNA
SCHEMBL9676766 0.82 HTT (0.44) HTTTP53AKR1B1LMNAALDH1A1
SCHEMBL5490141 0.81 TP53 (0.56) HTTTP53EIF4A1LMNAALOX12
SCHEMBL3391556 0.81 ALDH1A1 (0.53) HTTTP53EIF4A1GABRPGABRD
SCHEMBL2049816 0.81 HTT (0.46) HTTLMNAALOX12ALDH1A1TDP1
SCHEMBL9679692 0.81 ESR1 (0.43) HTTTP53AKR1B1LMNAALDH1A1
SCHEMBL8646438 0.81 ESR1 (0.43) HTTTP53AKR1B1LMNAALDH1A1
SCHEMBL5695814 0.81 ESR1 (0.43) HTTTP53AKR1B1LMNAALDH1A1
SCHEMBL9678240 0.81 ESR1 (0.43) HTTTP53AKR1B1LMNAALDH1A1
SCHEMBL9678182 0.81 ESR1 (0.43) HTTTP53AKR1B1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011072241-A9 4-OXO-1H-QUINOLINE-3-CARBOXAMIDES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-06-14 WO disclosed